Cazanat Cabozantinib 40mg tablets

Bottle of 40mg Capsule

4.5 (154)

7,800

Cazanat 40mg Capsule is a tyrosine kinase inhibitor used to treat progressive, metastatic medullary thyroid cancer, advanced renal cell carcinoma, and hepatocellular carcinoma in patients previously treated with sorafenib. It works by blocking multiple receptor tyrosine kinases—including VEGFR-1, -2, -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2—that are involved in tumor growth and blood supply, helping slow or stop cancer progression.

Description

Preface of Cabozantinib 40mg tablets:

Cazanat 40mg capsule is a tyrosine kinase asset used to treat advanced renal cell melanoma, hepatocellular melanoma, and medullary thyroid cancer.

Uses of Cabozantinib 40mg tablets:

  • Progressive, metastatic medullary thyroid cancer
  • Advanced renal cell carcinoma
  • Hepatocellular carcinoma (in patients previously treated with sorafenib)

Medium of Action of Cabozantinib 40mg tablets:

Cazanat 40mg Tablet works by inhibiting specific receptor tyrosine kinases, including VEGFR-1, -2, and -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2 — proteins involved in tumor growth and the blood supply that feeds cancer cells. By blocking these pathways, it helps slow or stop the progression of the disease.

Contact Us

Info Table
Manufacturer Natco
Prescription/Non prescription Prescription
Composition Cabozantinib 40mg
Brand Cazanat 40mg tablets
Packaging Size 30 tablets
Treatment to treat advanced renal cell carcinoma
Vendor Info
Benefits
Reviews

Description

Preface of Cabozantinib 40mg tablets:

Cazanat 40mg capsule is a tyrosine kinase asset used to treat advanced renal cell melanoma, hepatocellular melanoma, and medullary thyroid cancer.

Uses of Cabozantinib 40mg tablets:

  • Progressive, metastatic medullary thyroid cancer
  • Advanced renal cell carcinoma
  • Hepatocellular carcinoma (in patients previously treated with sorafenib)

Medium of Action of Cabozantinib 40mg tablets:

Cazanat 40mg Tablet works by inhibiting specific receptor tyrosine kinases, including VEGFR-1, -2, and -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2 — proteins involved in tumor growth and the blood supply that feeds cancer cells. By blocking these pathways, it helps slow or stop the progression of the disease.

Contact Us

Reviews

There are no reviews yet.

Be the first to review “Cazanat Cabozantinib 40mg tablets”

Your email address will not be published. Required fields are marked *

Frequently Asked Questions

From sourcing to delivery, we ensure reliability at every step. Our operations follow strict quality and regulatory standards.

What is Cabozantinib 40mg Tablets used for?
Cabozantinib 40mg Tablets (Cazanat) are used to treat progressive, metastatic medullary thyroid cancer, advanced renal cell carcinoma, and hepatocellular carcinoma in patients previously treated with sorafenib.
It’s a tyrosine kinase inhibitor that blocks multiple receptor tyrosine kinases — including VEGFR-1, -2, -3, KIT, TRKB, FLT-3, AXL, RET, MET, and TIE-2 — that are involved in tumor growth and blood supply, helping slow or stop cancer progression.
It’s typically prescribed for patients with advanced or metastatic thyroid, kidney, or liver cancer, including those who’ve already been treated with sorafenib without success. Always follow your doctor’s dosing instructions.
It’s generally used on its own as a targeted therapy, based on the specific cancer type and stage. Your oncologist will determine the right treatment plan for your case.
Cazanat 40mg is manufactured by Natco and contains Cabozantinib 40mg as its active composition, supplied in packs of 30 tablets.
For detailed clinical and safety information, refer to MedlinePlus Drug Information, a trusted external medical resource.

Related products